These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

856 related items for PubMed ID: 24779677

  • 1. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z, Xing L, Chen Y, Xu Y, Yang F, Zhang C, Ping Q, Xiao Y.
    Mol Pharm; 2014 Jun 02; 11(6):1823-34. PubMed ID: 24779677
    [Abstract] [Full Text] [Related]

  • 2. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
    Chen H, Qin Y, Zhang Q, Jiang W, Tang L, Liu J, He Q.
    Eur J Pharm Sci; 2011 Sep 18; 44(1-2):164-73. PubMed ID: 21782939
    [Abstract] [Full Text] [Related]

  • 3. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats.
    Pang Z, Feng L, Hua R, Chen J, Gao H, Pan S, Jiang X, Zhang P.
    Mol Pharm; 2010 Dec 06; 7(6):1995-2005. PubMed ID: 20957995
    [Abstract] [Full Text] [Related]

  • 4. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
    Ye Y, Sun Y, Zhao H, Lan M, Gao F, Song C, Lou K, Li H, Wang W.
    Int J Pharm; 2013 Dec 15; 458(1):110-7. PubMed ID: 24126038
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
    Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, Men Y, Zhang Y, Li RJ, Yang TY, Shang DW, Lou JN, Zhang LR, Zhang Q.
    J Control Release; 2010 Jan 25; 141(2):183-92. PubMed ID: 19799948
    [Abstract] [Full Text] [Related]

  • 13. Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma.
    Li H, Tong Y, Bai L, Ye L, Zhong L, Duan X, Zhu Y.
    Int J Biol Macromol; 2018 Feb 25; 107(Pt A):204-211. PubMed ID: 28863897
    [Abstract] [Full Text] [Related]

  • 14. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP, Cascante A, Brugada Vilà P, Gómez-Vallejo V, Llop J, Borrós S.
    Int J Pharm; 2018 Dec 20; 553(1-2):169-185. PubMed ID: 30321641
    [Abstract] [Full Text] [Related]

  • 15. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, Men Y, Guo J, Zhang Y, Li RJ, Zhou J, Lou JN, Wang JC, Zhang X, Zhang Q.
    Mol Pharm; 2009 Dec 20; 6(3):905-17. PubMed ID: 19344115
    [Abstract] [Full Text] [Related]

  • 16. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
    Geldenhuys W, Wehrung D, Groshev A, Hirani A, Sutariya V.
    Pharm Dev Technol; 2015 Jun 20; 20(4):497-506. PubMed ID: 24597667
    [Abstract] [Full Text] [Related]

  • 17. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
    Xu X, Li J, Han S, Tao C, Fang L, Sun Y, Zhu J, Liang Z, Li F.
    Eur J Pharm Sci; 2016 Jun 10; 88():178-90. PubMed ID: 26965003
    [Abstract] [Full Text] [Related]

  • 18. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
    Gao JQ, Lv Q, Li LM, Tang XJ, Li FZ, Hu YL, Han M.
    Biomaterials; 2013 Jul 10; 34(22):5628-39. PubMed ID: 23628475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC, Chen YC.
    Int J Pharm; 2015 Feb 01; 479(1):138-49. PubMed ID: 25560309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.